Edward Graham-Brown

Edward Graham-Brown has a wealth of experience in the life sciences and medical media industry. Edward began their career with SmithKline Beecham KK as a Post Marketing Surveillance Manager from 1994 to 1998. Edward then joined Amersham Pharmacia Biotech KK as a Marketing Manager from 1998 to 2000.

Moving on, Graham-Brown transitioned to GE Healthcare in 2000, where they held the role of Director of Business Development until 2002. From 2002 to 2003, they served as the Director of Strategic Planning, responsible for developing and communicating long-term plans. In 2003, they became the Director of Marketing Operations, and in 2004, they took on the role of Head of Bioprocess Industrial Marketing, where they had partial profit and loss responsibility for a leading industrial bioprocessing business.

In 2005, Graham-Brown joined EMD Millipore as Vice President of Filtration, Purification & Chromatography, overseeing a $400M bioprocessing business. In 2006, they were promoted to Vice President of Strategic Marketing, where they managed deal making, marketing research, global marketing communication, strategic business analysis, and more. Edward contributed to doubling the value of Millipore from 2005 to 2009 and successfully repositioned the Millipore corporate brand.

After leaving EMD Millipore, Graham-Brown had a transitional period as a Life Sciences Executive before joining Irvine Scientific in 2015. At Irvine Scientific, they held the position of Head of Business Development & Strategy, contributing to the company's development and manufacture of cell culture media, reagents, and medical devices for various healthcare sectors.

Overall, Graham-Brown's work experience showcases their expertise in strategic marketing, business development, and leadership roles within the life sciences and medical media industry.

Edward Graham-Brown's education history begins with their Bachelor of Pharmacy (BPharm) degree from King's College London, which they pursued from 1985 to 1988. During this time, they specialized in Medicinal and Pharmaceutical Chemistry. Following this, they obtained a Master of Business Administration (MBA) degree in International Business and Marketing from McGill University, studying from 1998 to 2000. Additionally, Edward received the Pharmaceutical Pre-Registration Certification from the Royal Pharmaceutical Society in London in September 1988. Edward also completed two certification programs offered by the University of Chicago Booth School of Business: the Strategic Leadership Program in 2011 and the Mergers and Acquisitions Program in 2012. However, specific months and years of completion for these programs are not provided. Edward has no recorded education experience at Brighton Hove and Sussex Sixth Form College or The University of Chicago Booth School of Business.